481 related articles for article (PubMed ID: 1573408)
21. [New approaches in the evaluation of sympathoadrenal system activity during periods of rest and stress].
Kvetnanský R
Bratisl Lek Listy; 1996 Feb; 97(2):72-83. PubMed ID: 8689310
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
23. Plasma catecholamines and urinary excretion of their main metabolites in three models of portal hypertension.
Rodríguez-Puyol D; Alsasua A; Santos JC; Blanchart A; López-Novoa JM
Clin Physiol Biochem; 1988; 6(6):301-9. PubMed ID: 3208482
[TBL] [Abstract][Full Text] [Related]
24. Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans.
Eisenhofer G; Brush JE; Cannon RO; Stull R; Kopin IJ; Goldstein DS
J Clin Endocrinol Metab; 1989 Feb; 68(2):247-55. PubMed ID: 2563731
[TBL] [Abstract][Full Text] [Related]
25. Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations.
Rasmussen DD; Ishizuka B; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1983 Oct; 57(4):760-3. PubMed ID: 6885965
[TBL] [Abstract][Full Text] [Related]
26. Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid.
Eldrup E; Møller SE; Andreasen J; Christensen NJ
Clin Sci (Lond); 1997 Apr; 92(4):423-30. PubMed ID: 9176043
[TBL] [Abstract][Full Text] [Related]
27. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans.
Goldstein DS; Cannon RO; Quyyumi A; Chang P; Duncan M; Brush JE; Eisenhofer G
J Auton Nerv Syst; 1991 Jun; 34(1):17-35. PubMed ID: 1940014
[TBL] [Abstract][Full Text] [Related]
28. Effects of single or repeated immobilization on release of norepinephrine and its metabolites in the central nucleus of the amygdala in conscious rats.
Pacák K; Palkovits M; Kvetnanský R; Fukuhara K; Armando I; Kopin IJ; Goldstein DS
Neuroendocrinology; 1993 Apr; 57(4):626-33. PubMed ID: 8367029
[TBL] [Abstract][Full Text] [Related]
29. Plasma catecholamines and their metabolites in obsessive-compulsive disorder.
Benkelfat C; Mefford IN; Masters CF; Nordahl TE; King AC; Cohen RM; Murphy DL
Psychiatry Res; 1991 Jun; 37(3):321-31. PubMed ID: 1891512
[TBL] [Abstract][Full Text] [Related]
30. Normal-range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report.
Orecchia G; Frattini P; Cucchi ML; Santagostino G
Dermatology; 1994; 189(4):350-3. PubMed ID: 7873818
[TBL] [Abstract][Full Text] [Related]
31. Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment.
Handa RJ; Hejna GM; Lorens SA
Brain Res; 1997 Mar; 751(1):131-8. PubMed ID: 9098576
[TBL] [Abstract][Full Text] [Related]
32. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
Karoum F; Suddath RL; Wyatt RJ
Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931
[TBL] [Abstract][Full Text] [Related]
33. Effect of handling and forced immobilization on rat plasma levels of epinephrine, norepinephrine, and dopamine-beta-hydroxylase.
Kvetnansky R; Sun CL; Lake CR; Thoa N; Torda T; Kopin IJ
Endocrinology; 1978 Nov; 103(5):1868-74. PubMed ID: 748021
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
Koulu M; Scheinin M; Kaarttinen A; Kallio J; Pyykkö K; Vuorinen J; Zimmer RH
Br J Clin Pharmacol; 1989 Feb; 27(2):243-55. PubMed ID: 2469451
[TBL] [Abstract][Full Text] [Related]
35. DOPA, dopamine, and DOPAC concentrations in the rat gastrointestinal tract decrease during fasting.
Eldrup E; Richter EA
Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E815-22. PubMed ID: 11001763
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous measurement of urinary and plasma norepinephrine, epinephrine, dopamine, dihydroxyphenylalanine, and dihydroxyphenylacetic acid by coupled-column high-performance liquid chromatography on C8 and C18 stationary phases.
Benedict CR
J Chromatogr; 1987 Jan; 385():369-75. PubMed ID: 3104375
[TBL] [Abstract][Full Text] [Related]
37. Prolonged changes in plasma concentrations of catecholamine metabolites following a single infusion of an MPTP analog.
Johannessen JN; Goldstein DS; Oliver J; Markey SP
Life Sci; 1990; 47(21):1895-901. PubMed ID: 2266773
[TBL] [Abstract][Full Text] [Related]
38. Adrenomedullary secretion of DOPA, catecholamines, catechol metabolites, and neuropeptides.
Chritton SL; Chinnow SL; Grabau C; Dousa MK; Lucas D; Roddy D; Yaksh TL; Tyce GM
J Neurochem; 1997 Dec; 69(6):2413-20. PubMed ID: 9375673
[TBL] [Abstract][Full Text] [Related]
39. Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study.
Pacak K; Armando I; Fukuhara K; Kvetnansky R; Palkovits M; Kopin IJ; Goldstein DS
Brain Res; 1992 Aug; 589(1):91-6. PubMed ID: 1422825
[TBL] [Abstract][Full Text] [Related]
40. Rapid procedure for chromatographic isolation of DOPA, DOPAC, epinephrine, norepinephrine and dopamine from a single urinary sample at endogenous levels.
Dalmaz Y; Peyrin L
J Chromatogr; 1978 Jan; 145(1):11-27. PubMed ID: 621235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]